Bleakley Financial Group »

ZIOPHARM Oncology shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of ZIOPHARM Oncology shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in ZIOPHARM Oncology

Tip: Access up to 7 years of quarterly data

All positions including ZIOPHARM Oncology held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ZIOPHARM Oncology by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0k 14k 0.07
2023-09-30 $1.9k 14k 0.13
2023-06-30 $7.4k 15k 0.51
2023-03-31 $8.6k 14k 0.63
2022-12-31 $9.6k 15k 0.65

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Sprott Physical Gold & Silve Tr Unit (CEF)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Bleakley Financial Group

Top funds holding ZIOPHARM Oncology

Horizon Kinetics Asset Management
Sawtooth Asset Management
Owen LaRue
Tucker Asset Management
CWM
EverSource Wealth Advisors

View all funds holding ZIOPHARM Oncology